ProQR Therapeutics N.V. financials at a glance

+ Portfolio

The revenue of ProQR Therapeutics N.V. is reported as 0.0052 billion Dollars in the fiscal year 2023. The earnings were -1 Dollars per share in 2023, which was 5.66 higher than 2021. And about -0.07546 billion Dollars are reported as free cash flow in the financials of ProQR Therapeutics N.V. 2023. No dividends were paid to the shareholders of the ProQR Therapeutics N.V. stock NasdaqCM:PRQR in the financial year 2023.

$5.20M

Revenue

$-1.00

Earnings Per Share

100.00%

Gross Margin %

$-74.98M

Free Cash Flow

Revenue

5.20

Earnings Per Share

-1.00

Gross Margin %

100.00

Free Cash Flow

-74.98

Financials

Year	Year	TTM	2022	2021	2020	2019	2018	2017	2016	2015	2014
Rev.	Revenue	N/A	$5.20M	$2.71M	$11.56M	$2.10M	$6.55M	$1.83M	$1.94M	$3.60M	$0.00M
GM %	Gross Margin %	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-0.46	$-1.00	$-1.06	$-1.14	$-1.50	$-1.24	$-2.10	$-1.78	$-0.99	$-1.24
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	0	0	0	0
Sha.	Shares	N/AM	80.82M	71.29M	50.2M	49.75M	38.87M	31.92M	23.35M	23.35M	23.34M
OCF	Operating Cash Flow	N/A	$-74.22M	$-28.98M	$-55.69M	$-48.32M	$-34.89M	$-42.68M	$-36.33M	$-26.97M	$-16.22M
FCF	Free Cash Flow	N/A	$-74.98M	$-29.52M	$-56.78M	$-48.96M	$-35.25M	$-42.80M	$-38.87M	$-28.42M	$-17.46M
FCFS	Free Cash Flow Per Share	$0.11	$-0.97	$-0.41	$-0.96	$-1.09	$-0.85	$-1.38	$-1.57	$-1.09	$-1.42

ProQR Therapeutics N.V. financials at a glance

Financials

Discover